MTOR and malignant colon neoplasm: This compound may rescue the decreased phosphorylation of glycogen synthase kinase 3 (GSK-3) in patients with type 2 diabetes.33 Activation of GSK-3 would then downregulate the PI3K-AKT-mTOR signaling pathway to inhibit colon cancer cell proliferation.34